Rob Ballinger
Development Associate IV, Biological Process Development at Alexion Pharmaceuticals, Inc.
Rob is a Development Associate IV with over 10 years of cell line development experience. He is part of the upstream process development group, leading projects in cell line development and upstream development. He has expertise from limited dilution cloning through bioreactor scale up. He is a subject matter expert on multiple high-throughput automated platforms, from microtiter plate liquid handling through high-throughput small scale bioreactor evaluation.